Hot Property: Hayden Research Campus
Dicerna Pharmaceuticals has leased an additional 107,283 square feet at the Hayden Research Campus, bringing its occupancy to more than 275,000 square feet in the town of Lexington.
Hobbs Brook Gets New CEO
Suburban developer Hobbs Brook Real Estate has named a new CEO to replace former chief executive Sam Schafer.
How Housing Choice Could Change a Town Center
The state’s Housing Choice zoning reform is spurring a conversation about density in one of the most unlikely places: Lexington’s quaint, history-filled town center.
Can Lexington Have It Both Ways?
After offering an incentive to lab developers by raising building heights, the town of Lexington is challenging them to deliver buildings equipped with some of the suburbs’ most energy-efficient building systems.
Momentum Grows for Office Park Redevelopments
Throughout eastern Massachusetts, once-shunned suburban office campuses are in demand for acquisitions amid developers’ newfound zeal both for office-to-lab conversions and sites with ample acreage to build biomanufacturing plants.
Can Lexington Get HIP?
Lexington is taking steps to make life science development more attractive amid rising competition from nearby suburbs and expanding clusters in Boston, Somerville and Watertown.
The Club of Million-Dollar Towns Keeps Growing
The number of towns with a median single-family home sale price of $1 million nearly quadrupled over the past eight years. And it is yet another sign as well that housing affordability in our state is going from bad to worse.
Hot Property: 91 Hartwell Ave.
Lexington officials have approved construction of a mixed-use campus at 91 Hartwell Ave. containing 125,000 square feet of office space and 95,000 square feet of class A lab facilities.
Hot Property: 75 Hayden Ave.
Four companies have signed leases for 75 Hayden Ave., a 214,440-square-foot life science facility at the Hayden Research Campus in Lexington.
Pharma Firm Adding More Space in Lexington
A pharmaceutical company that recently relocated its headquarters from West Cambridge to Lexington is leasing another 61,000 square feet in a neighboring building.
Hobbs Brook Management Makes $112M Lexington Purchase
Major Route 128 landlord Hobbs Brook Management is expanding its holdings in the area by more than 187,000 square feet.
Natural Gas Bans Are Worse than Useless – They’ll Hurt a Lot
Banning natural gas in new construction is a quick way to kill the economic miracle that has transformed the Boston area over the past half century from a rusting backwater to one of the planet’s top metros.
Lab Leasing Drives Development into New Markets
Kendall Square has seen achieved lab rents top $125 per square foot on a triple-net basis, leading tenants, landlords and investors to look to secondary clusters nearby.
Investors Paid $3.3B for Local Life Science Properties
With a combination of low vacancy, high demand and some of the highest asking rents in the country, life science properties in the Boston metro are more desirable than ever for investment firms, both large and small.
KabaFusion Joins Lexington Life Science Cluster
A specialist in home infusion IV therapies has signed a lease at 80 Hayden Ave. in Lexington for its new eastern headquarters.
Six Boston Suburbs Named Among ‘Best Small Cities in America’
Six Boston suburbs have been named among the 20 best small communities in America by a new analysis by personal finance site WalletHub, based on U.S. Census Bureau data.
Greater Boston Lab Space Grew 70 Percent in Last Decade
Massachusetts’ biotech industry is rapidly growing, but a new report makes clear just how much.
King Street Properties Named ‘Landlord of the Year’
Suburban life science developer King Street Properties has been named “Landlord of the Year” by the membership of the Greater Boston Real Estate Board Commercial Brokers Association.
Enterprise Bank Plans Branch in Lexington
Lowell-based Enterprise Bank plans to open a new branch in Lexington.
Lab-Ready Construction Is the New Norm
Upgrading office and industrial buildings to lab-ready space is paying off for a growing field of developers hoping to snare the next hot biotech startup transitioning from early-stage research to commercialization.
